5.44 - 5.64
4.95 - 8.28
2.1K / 2.4K (Avg.)
-272.00 | -0.02
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-1.44%
Negative revenue growth while VALMT.HE stands at 13.29%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
-1.81%
Negative gross profit growth while VALMT.HE is at 16.49%. Joel Greenblatt would examine cost competitiveness or demand decline.
-25.98%
Negative EBIT growth while VALMT.HE is at 300.00%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-25.98%
Negative operating income growth while VALMT.HE is at 300.00%. Joel Greenblatt would press for urgent turnaround measures.
-32.26%
Negative net income growth while VALMT.HE stands at 283.33%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-28.53%
Negative EPS growth while VALMT.HE is at 275.00%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-28.53%
Negative diluted EPS growth while VALMT.HE is at 275.00%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
-5.16%
Share reduction while VALMT.HE is at 4.86%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-5.16%
Reduced diluted shares while VALMT.HE is at 4.86%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
No Data
No Data available this quarter, please select a different quarter.
581.58%
OCF growth above 1.5x VALMT.HE's 6.98%. David Dodd would confirm a clear edge in underlying cash generation.
429.66%
FCF growth above 1.5x VALMT.HE's 12.50%. David Dodd would verify if the firm’s strategic investments yield superior returns.
-19.12%
Negative 10Y revenue/share CAGR while VALMT.HE stands at 4.81%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
-19.12%
Negative 5Y CAGR while VALMT.HE stands at 4.81%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
-24.93%
Negative 3Y CAGR while VALMT.HE stands at 4.81%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
538.22%
10Y OCF/share CAGR in line with VALMT.HE's 587.88%. Walter Schloss would see both as similarly efficient over the decade.
538.22%
5Y OCF/share CAGR is similar to VALMT.HE's 587.88%. Walter Schloss might see parallel cost profiles or expansions producing comparable cash flow.
439.86%
3Y OCF/share CAGR at 50-75% of VALMT.HE's 587.88%. Martin Whitman would suspect weaker recent execution or product competitiveness.
116.94%
Below 50% of VALMT.HE's 600.00%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
116.94%
Below 50% of VALMT.HE's 600.00%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
128.56%
Below 50% of VALMT.HE's 600.00%. Michael Burry suspects a steep short-term disadvantage in bottom-line expansion.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-12.76%
Negative 3Y equity/share growth while VALMT.HE is at 17.45%. Joel Greenblatt demands an urgent fix in capital structure or profitability vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
1.88%
AR growth well above VALMT.HE's 3.07%. Michael Burry fears inflated revenue or higher default risk in the near future.
0.06%
Inventory shrinking or stable vs. VALMT.HE's 8.60%. David Dodd confirms the company’s supply-chain is more efficient if sales are unaffected.
-0.31%
Negative asset growth while VALMT.HE invests at 3.02%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
1.94%
Positive BV/share change while VALMT.HE is negative. John Neff sees a clear edge over a competitor losing equity.
-2.98%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
No Data
No Data available this quarter, please select a different quarter.
7.12%
We expand SG&A while VALMT.HE cuts. John Neff might see the competitor as more cost-optimized unless we expect big payoffs from the overhead growth.